Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

848 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Randomized controlled phase II comparison study of concurrent chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil versus CCRT with cisplatin, 5-fluorouracil, methotrexate and leucovorin in patients with locally advanced squamous cell carcinoma of the head and neck.
Tsukuda M, Ishitoya J, Matsuda H, Horiuchi C, Taguchi T, Takahashi M, Nishimura G, Kawakami M, Watanabe M, Niho T, Kawano T, Ikeda Y, Sakuma Y, Shiono O, Komatsu M. Tsukuda M, et al. Among authors: sakuma y. Cancer Chemother Pharmacol. 2010 Sep;66(4):729-36. doi: 10.1007/s00280-009-1217-0. Epub 2009 Dec 24. Cancer Chemother Pharmacol. 2010. PMID: 20033810 Clinical Trial.
[Combined chemotherapy with docetaxel, cisplatin and 5-fluorouracil (TPF), and radiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN)].
Katori H, Tsukuda M, Ishitoya J, Mikami Y, Matsuda H, Tanigaki Y, Horiuchi C, Ikeda Y, Kimura M, Taguchi T, Hirose S, Yoshida T, Takahashi M, Sakuma Y, Yamamoto K, Sato N. Katori H, et al. Among authors: sakuma y. Nihon Jibiinkoka Gakkai Kaiho. 2005 Feb;108(2):157-63. doi: 10.3950/jibiinkoka.108.157. Nihon Jibiinkoka Gakkai Kaiho. 2005. PMID: 15765729 Japanese.
Analysis of feasibility and toxicity of concurrent chemoradiotherapy with S-1 for locally advanced squamous cell carcinoma of the head and neck in elderly cases and/or cases with comorbidity.
Tsukuda M, Ishitoya J, Mikami Y, Matsuda H, Horiuchi C, Taguchi T, Satake K, Kawano T, Takahashi M, Nishimura G, Kawakami M, Sakuma Y, Watanabe M, Shiono O, Komatsu M, Yamashita Y. Tsukuda M, et al. Among authors: sakuma y. Cancer Chemother Pharmacol. 2009 Oct;64(5):945-52. doi: 10.1007/s00280-009-0946-4. Epub 2009 Feb 15. Cancer Chemother Pharmacol. 2009. PMID: 19219603 Free PMC article.
Antiemetic effects of granisetron and dexamethasone combination therapy during cisplatin-containing chemotherapy for head and neck cancer: dexamethasone dosage verification trial.
Tsukuda M, Ishitoya J, Mikami Y, Matsuda H, Katori H, Horiuchi C, Kimura M, Taguchi T, Yoshida T, Nagao J, Sakuma Y, Toth G. Tsukuda M, et al. Among authors: sakuma y. Int J Clin Oncol. 2009 Aug;14(4):337-43. doi: 10.1007/s10147-008-0874-z. Epub 2009 Aug 25. Int J Clin Oncol. 2009. PMID: 19705245 Clinical Trial.
Treatment results and prognostic factors for advanced squamous cell carcinoma of the larynx treated with concurrent chemoradiotherapy.
Taguchi T, Nishimura G, Takahashi M, Komatsu M, Sano D, Sakuma N, Arai Y, Yamashita Y, Shiono O, Hirama M, Sakuma Y, Ishitoya J, Hata M, Ogino I, Oridate N. Taguchi T, et al. Among authors: sakuma n, sakuma y. Cancer Chemother Pharmacol. 2013 Oct;72(4):837-43. doi: 10.1007/s00280-013-2261-3. Cancer Chemother Pharmacol. 2013. PMID: 23959463
Concurrent chemoradiotherapy with docetaxel, cisplatin and 5-fluorouracil (TPF) in patients with locally advanced squamous cell carcinoma of the head and neck.
Komatsu M, Shiono O, Taguchi T, Sakuma Y, Nishimura G, Sano D, Sakuma N, Yabuki K, Arai Y, Takahashi M, Isitoya J, Oridate N. Komatsu M, et al. Among authors: sakuma n, sakuma y. Jpn J Clin Oncol. 2014 May;44(5):416-21. doi: 10.1093/jjco/hyu026. Epub 2014 Mar 30. Jpn J Clin Oncol. 2014. PMID: 24688084
848 results